Screening for new-onset diabetes after kidney transplantation: Limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin

Transplantation

Volumn 96, Issue 8, 2013, Pages 726-731

  Yates, Christopher J ^a   Fourlanos, Spiros ^a   Colman, Peter G ^a   Cohney, Solomon J ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Diabetes; NODAT; Posttransplantation; Prednisolone; Screening

Indexed keywords

BASILIXIMAB; GLUCOSE; HEMOGLOBIN A1C; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ARTICLE; CAPILLARY BLOOD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DRUG DOSE REDUCTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEW ONSET DIABETES AFTER TRANSPLANTATION; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY ANALYSIS;

ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; GLUCOCORTICOIDS; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MASS SCREENING; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; PREDNISOLONE; SENSITIVITY AND SPECIFICITY; TACROLIMUS;

EID: 84886100147     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a012f3     Document Type: Article

References (18)

1. Sharif A, Baboolal K. Complications associated with new-onset diabetes after kidney transplantation. Nat Rev Nephrol 2012; 8: 34.
2. Yates CJ, Fourlanos S, Hjelmesaeth J, et al. New-onset diabetes after kidney transplantation Vchanges and challenges. Am J Transplant 2012; 12: 820.
3. Valderhaug T, Hjelmesth J, Hartmann A, et al. The association of early post-transplant glucose levels with long-term mortality. Diabetologia 2011; 54: 1341.
4. Wilkinson A, Davidson J, Dotta F, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005; 19: 291.
5. Davidson JWA, Dantal J, Dotta F, et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February2003. Transplantation 2003; 75: S3.
6. Lane JT, Dagogo-Jack S. Approach to the patient with new-onset diabetes after transplant (NODAT). J Clin Endocrinol Metab 2011; 96: 3289.
7. Valderhaug TG, Jenssen T, Hartmann A, et al. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 2009; 88: 429.
8. Shah A, Kendall G, Demme RA, et al. Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation 2005; 80: 775.
9. Yates CJ, Cohney SJ, Colman PG, et al. Continuous glucose monitoring identifies reduced hyperglycaemia post kidney transplantation with split dose prednisolone. Diabetes 2012; 61: LB22.
10. Burt MG, Roberts GW, Aguilar-Loza NR, et al. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. J Clin Endocrinol Metab 2011; 96: 1789.
11. Report of a World Health Organization Consultation: Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 2011; 93: 299.
12. Sharif A, Baboolal K. Diagnostic application of the A(1c) assay in renal disease. J Am Soc Nephrol 2010; 21: 383.
13. Nathan DM, Balkau B, Bonora E, et al. International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327.
14. Hecking M, Werzowa J, Haidinger M, et al. Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant 2013; 28: 550.
15. Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabetes Med 2004; 21: 657.
16. Shabir S, Jham S, Harper L, et al. Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation. Transpl Int 2013; 26: 315.
17. Barr RG, Nathan DM, Meigs JB, et al. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002; 137: 263.
18. Florkowski C, Budgen C, Kendall D, et al. Comparison of blood glucose meters in a New Zealand diabetes centre. Ann Clin Biochem 2009; 46: 302.